author-photo

Shinji Atagi

251

Papers

4204

Citations

Citation Trend

Filter By

Papers (172) Sort By

Journal Conference Others

Adjuvant gefitinib versus cisplatin/vinorelbine in Japanese patients with completely resected, EGFR-mutated, stage II-III non-small cell lung cancer (IMPACT, WJOG6410L): A randomized phase 3 trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
MO2-5 Impact of pre-treatment AXL expression on EGFR-TKI efficacy in EGFR-mutated non-small cell lung cancer patients

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A randomized phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small cell lung cancer (JCOG1201/TORG1528).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Causal Relationship between Postoperative Recurrence and PD-L1 and EGFR Mutations in NSCLC: A Retrospective Cohort Study

2021
Show All
- Source
- Cite
- Save
Citations (0)
1332P A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR).

2021 Translational lung cancer research
Show All
- Source
- Cite
- Save
Citations (0)
Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report.

2021 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial

2021
Show All
- Source
- Cite
- Save
Citations (1)
1333P Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

2021 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)